DECA-DURABOLIN (nandrolone decanoate) by Teva is clinical pharmacology anabolic steroids are synthetic derivatives of testosterone. Approved for hiv wasting syndrome. First approved in 1962.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
DECA-DURABOLIN (nandrolone decanoate) is a synthetic anabolic steroid approved for HIV wasting syndrome, administered via intramuscular injection. It works by mimicking testosterone to promote anabolic effects, though complete dissociation of androgenic properties has not been achieved. The drug has been on the market since 1962 and is now approaching loss of exclusivity.
Sponsored by Teva, this legacy product faces moderate competitive pressure (30/100) with limited remaining exclusivity window, likely supporting a lean, maintenance-focused commercial team.
CLINICAL PHARMACOLOGY Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic…
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Worked on DECA-DURABOLIN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
DECA-DURABOLIN offers limited career growth opportunities given its LOE-approaching status and minimal linked job openings. Roles available are primarily in legacy product management, compliance, and field maintenance rather than strategic innovation or expansion.